DermTech Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:DermTech Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012886
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DermTech Inc (DermTech) is a precision medicine developer that offers molecular tests. The company’s products include adhesive skin sample collection kit and pigmented lesion assay. Its EGIR platform technology is applicable in non-invasive, genomic-based disease detection, theranostics, pharmaceutical research and cosmeceutical development. DermTech’s tests find application in the areas of clinical research and dermatology, medical diagnostics and prognostics, pharmaceutical research and development, and theranostics and treatment decision-making. The company develops tests to assist the clinical diagnosis of skin cancers and other skin conditions. DermTech is headquartered in La Jolla, California, the US.

DermTech Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DermTech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
DermTech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
DermTech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
DermTech Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
DermTech Inc, Medical Equipment, Deal Details 10
Venture Financing 10
DermTech Raises USD10 Million in Series C Financing 10
DermTech Raises Additional USD1 Million in Venture Financing 11
DermTech Raises USD2 Million in Venture Financing 12
DermTech Raises Additional USD2.55 Million in Venture Financing 13
DermTech Raises Additional USD1.8 Million in Venture Financing 14
DermTech Raises Additional USD0.77 Million in Financing Round 15
DermTech Raises USD0.58 Million in Venture Financing 16
DermTech Raises USD2.4 Million in Venture Financing 17
DermTech Raises US$5.6 Million In Initial Closing Of Series B Financing 18
Partnerships 19
DermTech Enters into Agreement with Dermpath Diagnostics 19
Equity Offering 20
DermTech Withdraws IPO 20
DermTech Inc – Key Competitors 21
DermTech Inc – Key Employees 22
DermTech Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
Nov 07, 2017: DermTech Announces Addition of Harold Rabinovitz to Scientific Advisory Board 24
Sep 12, 2017: DermTech Appoints Gerald Krueger, MD, to Scientific Advisory Board 25
Aug 23, 2017: DermTech Announces Addition to Board of Directors 26
Jul 11, 2016: DermTech Announces Expansion of Board of Directors and Commercial Team 27
Legal and Regulatory 28
Apr 20, 2016: DermTech Receives CAP Accreditation 28
Product News 29
Apr 27, 2017: DermTech’s Utility Study Published in JAMA Dermatology 29
Mar 13, 2017: DermTech Presents Four Molecular Dermatology Studies at AAD 2017 30
03/08/2016: DermTech’s Late Breaking Abstract Presented at AAD 31
Other Significant Developments 32
Jan 09, 2017: DermTech Provides Business Update 32
May 02, 2016: DermTech Announces Preferred Provider Agreements with TriCare and ACPN and Credentialing by UnitedHealthcare 33
Mar 15, 2016: DermTech Enters Into Preferred Provider Agreements with Multiplan and FedMed 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
DermTech Inc, Medical Equipment, Key Facts 2
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
DermTech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
DermTech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
DermTech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
DermTech Inc, Deals By Market, 2011 to YTD 2017 8
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
DermTech Raises USD10 Million in Series C Financing 10
DermTech Raises Additional USD1 Million in Venture Financing 11
DermTech Raises USD2 Million in Venture Financing 12
DermTech Raises Additional USD2.55 Million in Venture Financing 13
DermTech Raises Additional USD1.8 Million in Venture Financing 14
DermTech Raises Additional USD0.77 Million in Financing Round 15
DermTech Raises USD0.58 Million in Venture Financing 16
DermTech Raises USD2.4 Million in Venture Financing 17
DermTech Raises US$5.6 Million In Initial Closing Of Series B Financing 18
DermTech Enters into Agreement with Dermpath Diagnostics 19
DermTech Withdraws IPO 20
DermTech Inc, Key Competitors 21
DermTech Inc, Key Employees 22

★海外企業調査レポート[DermTech Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polydex Pharmaceuticals Ltd (POLXF):企業の財務・戦略的SWOT分析
    Summary Polydex Pharmaceuticals Ltd (PPL) is a manufacturer and marketer of pharmaceutical intermediates for human and veterinary pharmaceutical markets. The company manufactures and sells bulk quantities of dextran and derivative products. Its dextran and its derivatives can be used as adjuvants, e …
  • Continuum Wind Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Continuum Wind Energy Ltd (Continuum Wind Energy), a subsidiary of Morgan Stanley Infrastructure Partners LP is a renewable energy company that constructs and develops wind farms and wind energy generation. The company's services include optimization of number of wind turbines to maximize ge …
  • Catalina Holdings (Bermuda) Ltd:企業のM&A・事業提携・投資動向
    Catalina Holdings (Bermuda) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalina Holdings (Bermuda) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tobishima Corporation:企業の戦略・SWOT・財務情報
    Tobishima Corporation - Strategy, SWOT and Corporate Finance Report Summary Tobishima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Electricite de France SA (EDF):企業の財務・戦略的SWOT分析
    Electricite de France SA (EDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • American Tower Corporation:企業の戦略・SWOT・財務情報
    American Tower Corporation - Strategy, SWOT and Corporate Finance Report Summary American Tower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Syncardia Systems LLC-医療機器分野:企業M&A・提携分析
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • Xtant Medical Holdings Inc (XTNT)-医療機器分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • iDD biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary iDD biotech SAS (iDD biotech) is a healthcare products provider that discovers and develops differentiated therapeutic antibodies. The company's products comprise pre-clinical stage therapeutic monoclonal antibodies and active drug discovery programs. It develops therapies for the treatment …
  • Labrador Iron Mines Holdings Limited:企業の戦略・SWOT・財務分析
    Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Cobb Electric Membership Corporation:企業の戦略的SWOT分析
    Cobb Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company’s pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. …
  • Berkshire Hathaway Inc:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • Comet Ridge Ltd (COI):企業の財務・戦略的SWOT分析
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆